HIV News and Research

RSS

Research roundup: Patients' unrealistic expectations for chemo; Neighborhood may affect CPR rates; Rate hike reviews working

"To make informed decisions about whether to receive chemotherapy, patients with advanced lung or colorectal cancer need a realistic understanding of its likely benefits," the authors write. Researchers conducted comprehensive reviews of records.

29 Oct 2012

Malawi needs donor support to maintain HIV/AIDS treatment program

In the last of a series of posts on the U.K. Department for International Development's (DfID) blog examining the department's work in Malawi, Neil Squires, DfID head of profession for health, looks at the sustainability of the country's HIV/AIDS program.

26 Oct 2012

Associated Press examines access to antiretroviral treatment in Myanmar

The Associated Press examines access to antiretroviral treatment in Myanmar, which "ranks among the world's hardest places to get HIV care, and health experts warn it will take years to prop up a broken health system hobbled by decades of neglect."

26 Oct 2012

Central African Republic town struggling to provide health care since withdrawal of foreign companies, VOA reports

VOA News examines how the 2009 withdrawal of foreign diamond-mining companies from the small town of Carnot in the Central African Republic (CAR) affected the local economy and access to health care for residents.

26 Oct 2012

USPTO issues patent to Tobira’s cenicriviroc for treatment of HIV-1 infection

Tobira Therapeutics, Inc., developer of innovative antiretroviral therapies for HIV, today announced the United States Patent and Trademark Office has issued patent 8,183,273, claiming compositions of matter of a broad family of compounds with activity against chemokine receptors CCR5 and CCR2.

26 Oct 2012

Indonesia plans to include HIV treatment in universal health care coverage

During a meeting with UNAIDS Executive Director Michel Sidibe on Tuesday, Indonesia Minister of Health Nafsiah Mboi "pledged to scale up HIV testing and treatment programs" with a "focus on 141 districts where key affected populations are the highest," a UNAIDS feature story reports.

25 Oct 2012

Examining the need for TB indicators, activities in global AIDS response blueprint

In a post in the Center for Global Health Policy's "Science Speaks" blog, Lucica Ditiu, executive secretary of the Stop TB Partnership, examines the need to include tuberculosis (TB) in the global AIDS response blueprint that Secretary of State Hillary Clinton announced at the XIX International AIDS Conference.

25 Oct 2012

Communicable diseases responsible for majority of deaths in Africa, WHO official says

Speaking on Monday in Luanda, Angola, at the opening session of the inaugural meeting on Medical Education, sponsored by the Faculty of Medicine of Agostinho Neto University, WHO Regional Director for Africa Luis Gomes Sambo said communicable diseases account for 63 percent of deaths in Africa, with HIV and tuberculosis (TB) responsible for the majority of those, the Angola Press reports.

25 Oct 2012

New method of oral vaccination could help boost immunity to TB, influenza and C. difficile

Scientists at Royal Holloway, University of London have developed a pioneering new method of oral vaccination which could help boost immunity to TB and influenza, as well as prevent C. difficile for which there is currently no vaccine.

25 Oct 2012

Blueprint for AIDS-free generation must allow HIV funds to be used for family planning

In the Huffington Post's "Politics" blog, Serra Sippel, president of the Center for Health and Gender Equity, notes that Secretary of State Hillary Rodham Clinton said at the XIX International AIDS Conference in July that all women should be able to decide "when and whether to have children" and that PEPFAR, in a guidance released last week.

24 Oct 2012

Cardiovascular disease risk varies with HIV subgroup

The ability of lipids to predict risk for cardiovascular disease may be weakened in women who are infected with HIV, report researchers.

23 Oct 2012

KIF3A protein ferries HIV to the plasma membrane

A study in The Journal of Cell Biology identifies a motor protein that ferries HIV to the plasma membrane, helping the virus escape from macrophages.

23 Oct 2012

Researchers discover how HIV-infected people develop very powerful antibody responses

Wits researchers have played a pivotal role in an AIDS study published today in the journal, Nature Medicine, which describes how a unique change in the outer covering of the virus found in two HIV infected South African women enabled them to make potent antibodies which are able to kill up to 88% of HIV types from around the world.

23 Oct 2012

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

Sanofi Pasteur, the vaccines division of Sanofi, presented today an overview of Phase II and Phase III clinical trials for its investigational quadrivalent influenza vaccine (QIV).

23 Oct 2012

Primary care physicians miss hepatitis vaccine targets

Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.

22 Oct 2012

Researchers continue hunt for AIDS vaccine

"Finding a safe, effective AIDS vaccine has, thus far, proved elusive even after some $8 billion invested from 2001-2011 into vaccine research and development," PlusNews reports in an article examining ongoing HIV vaccine research efforts. "Scientists point to HIV's Houdini-like ability to escape immune system attack, and less-than-strategic use of funds over the past decade, as reasons for the continued hunt," the news service writes.

22 Oct 2012

Blog reports on ID Week in San Diego

The Center for Global Health Policy's "Science Speaks" blog on Friday published two posts reporting on ID Week, which concluded in San Diego on Sunday.

22 Oct 2012

PLoS ONE publishes review of AntiViral-HyperActivation Limiting Therapeutics clinical trial

ViroStatics, a private Italian/American biopharmaceutical company developing novel therapeutics for viral and other chronic diseases, announced that a review of the first human clinical trial to test a new class of anti-HIV medications known as AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) has been published in the peer-reviewed journal PLoS ONE.

22 Oct 2012

Mistakes are still commonly made in prescriptions of antiretroviral medications

Research presented at IDWeek 2012- concludes that despite advances in electronic medical records, mistakes are still commonly made in the prescription of antiretroviral medications for hospitalized HIV-positive patients. At the same time, a trio of studies suggests however, that electronic records in combination with increased clinical education can help to greatly decrease medical errors.

20 Oct 2012

UNDP releases report examining impact of laws regarding sex work, effectiveness of HIV response

The UNDP on Thursday released a report, titled "Sex Work and the Law," which "examines 48 countries in Asia and the Pacific to assess laws, legal policies and law enforcement practices that affect the human rights of sex workers and impact on the effectiveness of HIV responses," according to a UNDP press release.

20 Oct 2012

HIV News and Research

Research roundup: Patients' unrealistic expectations for chemo; Neighborhood may affect CPR rates; Rate hike reviews working

Malawi needs donor support to maintain HIV/AIDS treatment program

Associated Press examines access to antiretroviral treatment in Myanmar

Central African Republic town struggling to provide health care since withdrawal of foreign companies, VOA reports

USPTO issues patent to Tobira’s cenicriviroc for treatment of HIV-1 infection

Indonesia plans to include HIV treatment in universal health care coverage

Examining the need for TB indicators, activities in global AIDS response blueprint

Communicable diseases responsible for majority of deaths in Africa, WHO official says

New method of oral vaccination could help boost immunity to TB, influenza and C. difficile

Blueprint for AIDS-free generation must allow HIV funds to be used for family planning

Cardiovascular disease risk varies with HIV subgroup

KIF3A protein ferries HIV to the plasma membrane

Researchers discover how HIV-infected people develop very powerful antibody responses

Sanofi presents overview of Phase II and III trials for quadrivalent influenza vaccine

Primary care physicians miss hepatitis vaccine targets

Researchers continue hunt for AIDS vaccine

Blog reports on ID Week in San Diego

PLoS ONE publishes review of AntiViral-HyperActivation Limiting Therapeutics clinical trial

Mistakes are still commonly made in prescriptions of antiretroviral medications

UNDP releases report examining impact of laws regarding sex work, effectiveness of HIV response

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News